Orphan and Rare Disease Products: Driving Product Success, Patient Access
In Partnership With AmerisourceBergen | Apr 26, 2021 10:00am Rare diseases impact about 25 million people in the United States. The vast majority of rare diseases have no effective treatment, creating an urgent need for more research and development in this space. While there is a growing number of therapies in development for rare and ultra-rare conditions, manufacturers developing these products face unique challenges throughout the patient and product journey. AmerisourceBergen, a global healthcare company, has provided commercialization services for more than 100 rare dis...
Source: fiercebiotech.com